https://shkrt.cn/en/article/shkrt-exquisite-quartz-sink-products-now-available-on-alibaba-global-shop-10 2024-04-01T13:32:20.000Z https://shkrt.cn/en/article/merry-christmas-from-shkrt-11 2024-04-01T13:53:25.384Z https://shkrt.cn/en/article/happy-new-year-2024-here-are-the-best-wishes-messages-from-shkrt-12 2024-04-01T14:06:26.780Z https://shkrt.cn/en/article/happy-lunar-new-year-2024-of-the-loong-13 2024-04-01T14:14:14.809Z https://shkrt.cn/en/article/shkrt-offers-20-discount-for-alibabas-march-procurement-festival-14 2024-04-02T13:03:02.123Z https://shkrt.cn/en/article/qingming-festival-holiday-notice-15 2024-04-02T13:08:17.193Z https://shkrt.cn/en/article/labor-day-holiday-notice-16 2024-04-30T14:39:10.642Z https://shkrt.cn/en/article/happy-dragon-boat-festival-holiday-17 2024-06-08T10:20:37.307Z https://shkrt.cn/en/article/shkrt-recently-launched-alibaba-guaranteed-with-incredibly-low-prices-18 2024-07-19T10:25:14.148Z https://shkrt.cn/en/article/approval-for-clinical-trials-of-sk08-20 2024-09-18T11:53:29.286Z https://shkrt.cn/en/article/sk08-phase-i-clinical-trial-officially-enrolled-24 2024-09-14T03:46:51.387Z https://shkrt.cn/en/article/zhiyi-biotech-closes-cny110-million-b-round-for-live-biotherapeutics-development-28 2024-09-14T07:41:02.568Z https://shkrt.cn/en/article/successful-completion-of-phase-i-clinical-study-of-sk08-31 2024-09-14T07:45:05.793Z https://shkrt.cn/en/article/zybio-”-live-biotherapeutics-engineering-technology-research-center-of-guangdong-province-”-is-awarded-34 2024-09-14T07:49:43.785Z https://shkrt.cn/en/article/zhiyi-named-the-“future-unicorn”-of-guangzhou-innovative-enterprises-in-2021-37 2024-09-14T08:03:17.430Z https://shkrt.cn/en/article/zhiyi-biotech-raised-nearly-cny100-million-b-round-of-financing-to-accelerate-the-development-of-lbps-pipeline-38 2024-09-14T08:03:10.778Z https://shkrt.cn/en/article/the-application-for-clinical-trial-of-sk08-combined-with-immune-checkpoint-inhibitor-in-the-treatment-of-advanced-solid-tumors-was-accepted-40 2024-09-14T08:02:45.604Z https://shkrt.cn/en/article/news-the-application-for-the-clinical-trial-of-sk08-combined-with-anti-pd-1--l1-monoclonal-antibodies-in-treating-advanced-solid-tumors-was-approved-42 2024-09-14T08:05:40.448Z https://shkrt.cn/en/article/zhiyi-biotech-received-clinical-approval-from-us-fda-for-sk10-in-chemotherapy-induced-diarrhea-49 2024-09-14T08:32:13.718Z https://shkrt.cn/en/article/news-the-phase-i-clinical-trial-of-sk10-was-approved-by-the-us-ethics-committee-56 2024-09-14T09:17:00.636Z https://shkrt.cn/en/article/zhiyi-biotech-initiates-phase-iii-clinical-trial-for-sk08-in-china-58 2024-09-14T09:24:19.845Z https://shkrt.cn/en/article/news-the-phase-iii-clinical-trial-of-sk08-was-approved-and-subject-initiation-recruitment-68 2024-09-14T09:49:21.167Z https://shkrt.cn/en/article/zhiyi-biotech-successfully-completes-phase-i-clinical-trial-of-sk10-for-the-treatment-of-chemotherapy-induced-diarrhea-71 2024-09-14T09:58:02.434Z https://shkrt.cn/en/article/zhiyi-biotech-raised-nearly-cny100-million-c-round-of-financing-to-accelerate-the-phase-iii-clinical-research-74 2024-09-14T10:16:51.383Z https://shkrt.cn/en/article/zhiyi-biotech-raised-45-million-in-series-b-funding-round-to-accelerate-the-clinical-development-of-lbps-pipelines-75 2024-09-14T10:21:21.906Z